Advertisement
Screener

Janux Therapeutics, Inc. (JANX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Janux Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Janux Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $82.23M went out.
  • Fiscal year ended 2025-12-31: from investing, $300.98M went out.
  • Fiscal year ended 2025-12-31: from financing, $4.95M came in.
  • Fiscal year ended 2025-12-31: change in cash, $378.27M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNot split outChange in cash
2025-12-31-$82.23M-$300.98M$4.95M*-$378.27M
2024-12-31-$43.81M-$258.02M$713.24M*$411.40M
2023-12-31-$50.58M-$41.19M$59.55M*-$32.22M
2022-12-31-$42.92M$58.27M$500.00K*$15.84M
2021-12-31-$16.98M-$340.96M$386.52M*$28.59M
2020-12-31-$4.37M$0.00$11.52M*$7.16M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30$12.48M*-$38.78M*$2.24M*
2026-03-31-$12.34M$8.29M$3.54M-$506.00K
2025-12-31-$28.54M*$29.54M*$2.94M*
2025-09-30-$12.86M*$8.31M*
2025-06-30-$23.81M*$1.56M*$954.00K*
2025-03-31-$17.02M-$340.39M$901.00K-$356.86M
2024-12-31-$16.73M*$33.93M*$386.65M*
2024-09-30-$2.23M*$12.67M*$1.65M*
2024-06-30-$10.02M*-$190.88M*$2.77M*
2024-03-31-$14.84M-$113.74M$1.66M$320.51M*$193.60M
2023-12-31-$9.90M*$11.12M*$831.00K*
2023-09-30-$11.71M*-$61.45M*$56.61M*
2023-06-30-$15.05M*$17.87M*$528.00K*
2023-03-31-$13.91M-$8.74M$1.58M-$21.07M
2022-12-31-$11.91M*-$1.60M*
2022-09-30-$13.41M*$19.76M*
2022-06-30-$6.07M*$9.04M*
2022-03-31-$11.52M$31.07M$19.55M
2021-12-31-$10.48M*$7.33M*
2021-09-30-$5.85M*-$205.54M*$0.00*-$843.00K*
2021-06-30-$6.20M*-$142.60M*$329.66M*
2021-03-31$5.56M-$153.00K$57.55M*$62.96M
2020-12-31-$1.63M*$0.00*$4.55M*
2020-09-30-$1.08M*$0.00*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93